Le Lézard
Classified in: Health
Subject: NPT

Surge in Community Fundraising Events Fuels Nonprofit Optimism and Nationwide Revival


Join Us for Light The Night 2024!

MONTREAL, May 10, 2024 /CNW/ - Amidst a landscape of resilience and renewal, the Leukemia & Lymphoma Society of Canada proudly announces the triumphant return of Light The Night, scheduled to illuminate at Parc Jean-Drapeau, Espace Paddock on October 26, 2024. As peer-to-peer fundraising events continue to surge, Light The Night stands as a beacon of hope, unity, and communal strength, poised to deliver an unforgettable experience that celebrates the power of collective action.

In the wake of recent challenges, Light The Night's comeback heralds a renaissance of in-person engagement, promising participants an unparalleled evening that captures the essence of solidarity and support. Alicia Talarico, President of the Leukemia & Lymphoma Society of Canada, shares her heartfelt anticipation for the event's return. "After navigating uncertainties and prioritizing safety, we're thrilled to rekindle the magic of Light The Night in its truest form," said Talarico. "This year, we're committed to crafting an experience that ignites the spirit of our community and leaves an indelible mark on all who participate."

With an 8.9% increase in revenue for peer-to-peer fundraising events nationwide, Light The Night 2024 promises an evening of heightened entertainment, culinary delights, and opportunities for profound connections within the community. Participants will traverse a path illuminated by hope, honouring those affected by blood cancers and standing in solidarity against these diseases.

"Light The Night isn't just a walk; it's a testament to our resilience, our determination, and our unwavering commitment to the fight against blood cancers," Talarico emphasized. "As we come together under the stars, we embody the progress we've made and the hope that propels us forward."

Registration for Light The Night 2024 is now open at lightthenight.ca. Join us as we shine brighter together, forging a path of healing and support for those impacted by blood cancers.

About the Leukemia & Lymphoma Society of Canada:

The Leukemia & Lymphoma Society of Canada is a non-profit organization dedicated to finding cures and ensuring access to treatments for blood cancer patients. Through fundraising events like Light The Night, the Society provides support, education, and advocacy for individuals and families affected by blood cancers.

Note to Editors: High-resolution images and additional information about Light The Night 2024 are available upon request.

SOURCE The Leukemia & Lymphoma Society of Canada


These press releases may also interest you

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...

at 16:05
Illumina, Inc. announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice...

at 16:05
Peloton Interactive, Inc. ("Peloton") today announced that it intends to launch a global refinancing, pursuant to which it will offer $275.0 million aggregate principal amount of convertible senior notes due 2029 (the "notes") in a private offering...



News published on and distributed by: